Old Web
English
Sign In
Acemap
>
authorDetail
>
Tracy Burgess
Tracy Burgess
Genentech
Virology
Medicine
Internal medicine
Pharmacokinetics
Placebo
9
Papers
155
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)
2018
Mark H. Gotfried
Carlos E. Girod
Danielle Antin-Ozerkis
Tracy Burgess
John L. Stauffer
Klaus-Uwe Kirchgaessler
Maria Padilla
Show All
Source
Cite
Save
Citations (3)
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model
2017
Antimicrobial Agents and Chemotherapy
Jacqueline McBride
Jeremy J. Lim
Tracy Burgess
Rong Deng
Michael A. Derby
Mauricio Maia
Priscilla Horn
Omer Siddiqui
Daniel Sheinson
Haiyin Chen-Harris
Elizabeth Newton
Dimitri Fillos
Denise Nazzal
Carrie M. Rosenberger
Maikke B. Ohlson
Rob Lambkin-Williams
Hosnieh Fathi
Jeffrey M. Harris
Jorge A. Tavel
Show All
Source
Cite
Save
Citations (40)
Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients
2017
Antimicrobial Agents and Chemotherapy
Rong Deng
Yehong Wang
Mauricio Maia
Tracy Burgess
Jacqueline McBride
X. Charlene Liao
Jorge A. Tavel
William D. Hanley
Show All
Source
Cite
Save
Citations (4)
1